Results 71 to 80 of about 37,508 (242)

Efficacy and safety of pharmacotherapies for smoking cessation in anxiety disorders: Subgroup analysis of the randomized, active- and placebo-controlled EAGLES trial. [PDF]

, 2020
BackgroundSmoking rates are high in adults with anxiety disorders (ADs), yet little is known about the safety and efficacy of smoking-cessation pharmacotherapies in this group.MethodsPost hoc analyses in 712 smokers with AD (posttraumatic stress disorder
Anthenelli, Robert M, Ayers, Catherine R, Evins, A Eden, Heffner, Jaimee L, Lawrence, David, McRae, Thomas, Russ, Cristina   +6 more
core  

Effectiveness of a Psychiatrist‐Led Clinic for Metabolic Health in Severe Mental Illness: A Retrospective Chart Review Study

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Background Psychotropic medications are associated with serious metabolic adverse effects, which contribute to an increased risk of cardiometabolic comorbidities in patients with severe mental illness (SMI). Several intervention strategies are available to mitigate these metabolic adverse effects; however, data on their utility in real‐world ...
Nicolette Stogios, Femin Prasad, Riddhita De, Kateryna Maksyutynska, Akash PrasannaKumar, Vittal Korann, Tariq Ahmed, Marcos Sanches, Leah Burton, Mohammed A. Alarabi, Tanner Isinger, Michelle Desanti, Rebecca Oliveira, Daphne J. Korczak, Ariel Graff‐Guerrero, Gary Remington, Margaret K. Hahn, Sri Mahavir Agarwal   +17 more
wiley   +1 more source

Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study [PDF]

, 2017
Aim To investigate the safety and efficacy of bupropion sustained release (bupropion SR) in promoting abstinence from smoking in subjects with cardiovascular disease (CVD).
Astbury, C., Farsang, C., Hider, A., Klaene, G., Lewis, K., Manolis, A., Perruchoud, A.P., Silagy, C., Sweet, R., Tonstad, S., van Spiegel, P.I.   +10 more
core  

An update of a systematic review and meta‐analyses exploring flavours in intervention studies of e‐cigarettes for smoking cessation

Addiction, Volume 120, Issue 4, Page 770-778, April 2025.
Abstract Aims To determine patterns of e‐cigarette flavour use (sweet, tobacco, menthol/mint) in interventional studies of e‐cigarettes for stopping smoking, and to estimate associations between flavours and smoking/vaping outcomes. Methods Update of secondary data analyses, including meta‐analyses subgrouped by flavour provision and narrative ...
Nicola Lindson, Jonathan Livingstone‐Banks, Ailsa R. Butler, David T. Levy, Phoebe Barnett, Annika Theodoulou, Caitlin Notley, Nancy A. Rigotti, Yixian Chen, Jamie Hartmann‐Boyce   +9 more
wiley   +1 more source

Bupropion extended-release induced spontaneous orgasms [PDF]

Düşünen Adam Psikiyatri ve Nörolojik Bilimler Dergisi, 2014
Sexual side effects are common with antidepressant use. Spontaneous orgasms have been previously described with several antidepressants. We report the case of a woman who had spontaneous orgasms after starting 300mg/day bupropion extended-release ...
mehmet hamdi orum, oguzhan bekir egilmez, aysun kalenderoglu   +2 more
doaj  

RNAseq Analyses Identify Tumor Necrosis Factor-Mediated Inflammation as a Major Abnormality in ALS Spinal Cord [PDF]

, 2016
ALS is a rapidly progressive, devastating neurodegenerative illness of adults that produces disabling weakness and spasticity arising from death of lower and upper motor neurons.
A Al-Chalabi, A Chesi, A Dobin, A Hirano, A Kratz, A McKenna, A Saito, A Zhou, AB van Spriel, AE Renton, AM Bolger, AT Kwon, B Hoesel, B Ikiz, B Tian, B Zhang, C Cereda, C Figueroa-Romero, C Trapnell, Cedric Raoul, CG Saris, CM Higgins, CY Jin, D Brustolim, D Kim, D Kim, D Liu, D Nagy, D Schiffer, David G. Brohawn, DJ Park, ED Hall, EW Stommel, GA Van der Auwera, GN Babu, H Jeong, H Li, H Tanaka, IM Chiu, IR Holtman, J Ganesalingam, J Kong, J Satoh, James P. Bennett, JL Elliott, JS Henkel, JS Henkel, K Hattermann, K Hensley, KE Lewis, KM Mohler, L Probert, Laura C. O’Brien, LB Fanning, LC O'Brien, LJ Kogelman, M Damiano, M Hausmann, M Maschietto, M Mattiazzi, M Poloni, M Prudencio, MA DePristo, MD Robinson, ME Alexianu, ME Rusiniak, MG Hinds, MI Love, MJ Landrum, MR Turner, MW Amoroso, O Abel, O Hardiman, O Micheau, P Corcia, P Langfelder, PB Verghese, PD Stenson, PG Engstrom, PK Andrus, PR Heath, RJ Ferrante, S Abel, S Anders, S Byrne, S Hagl, S Horvath, S Khan, S Sasaki, S Sasaki, SL Carter, SN Dowey, SS Han, T Yoshihara, W Zhao, Y Chang, Y Ma, YJ Surh, Z Wang, ZH Zhang   +99 more
core   +8 more sources

Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review

Addiction, EarlyView.
Abstract Background and aims This is the first systematic review of the extant literature on all major psychedelic‐assisted treatment for alcohol use disorder (AUD), tobacco use disorder (TUD) and other substance use disorders (SUD). We aimed to summarise the evidence for efficacy of psychedelic‐assisted treatment for AUD, TUD, and SUD; to evaluate its
Theodore Piper, Francesca Small, Sam Brown, Michael Kelleher, Luke Mitcheson, James Rucker, Allan H. Young, John Marsden   +7 more
wiley   +1 more source

Charcoal hemoperfusion in bupropion overdose

Journal of the Formosan Medical Association, 2014
Bupropion is a relatively new and popular medication for depression, with seizures as its major side effect. In the literature, there are insufficient data about hemodialysis following bupropion overdose.
Hızır Ufuk Akdemir, Fatih Çalışkan, Latif Duran, Celal Katı, Bülent Güngörer, Metin Ocak   +5 more
doaj   +1 more source

Bupropion administration increases resting-state functional connectivity in dorso-medial prefrontal cortex [PDF]

, 2017
Background: Patients on the selective serotonergic re-uptake inhibitors (SSRI) like citalopram report emotional blunting. We have shown previously that citalopram reduces resting-state functional connectivity (RSFC) in healthy volunteers in a number of ...
Dean, Zola, McCabe, Ciara, Rzepa, Ewelina   +2 more
core   +1 more source

Nicotine pouches and clinical outcomes related to smoking cessation: A systematic review of randomized trials

Addiction, EarlyView.
Abstract Background and aims Tobacco‐free nicotine pouches (NPs) are oral nicotine products promoted by manufacturers and some researchers as tools that may reduce nicotine cravings and support smoking reduction or cessation. However, evidence regarding their actual clinical impact remains limited.
Javad Heshmati, Spencer Shahen, Emma Lynn Bates, Sarah Visintini, Evyanne Quirouette, Kerri‐Anne Mullen, Hassan Mir   +6 more
wiley   +1 more source